Contemporary and controversial aspects of the Maillard reaction products

Current Opinion in Food Science

Volumn 1, Issue 1, 2015, Pages 13-20

  Bastos, Deborah Helena Markowicz ^a   Gugliucci, Alejandro ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84961288113     PISSN: 22147993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cofs.2014.08.001     Document Type: Review

References (37)

1. Robert L, Labat-Robert J, Robert AM: The Maillard reaction. From nutritional problems to preventive medicine. Pathol Biol (Paris) 2010, 58:200-206.
2. Hodge JE: Dehydrated foods - chemistry of Browning reactions in model systems. J Agric Food Chem 1953, 1:928-943.
3. Henle T: Dietary advanced glycation end products - a risk to human health? A call for an interdisciplinary debate. Mol Nutr Food Res 2007, 51:1075-1078.
4. Kunkel HG, Wallenius G: New hemoglobin in normal adult blood. Science 1955, 122:288.
5. Rahbar S: An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 1968, 22:296.
6. Monnier VM, Stevens VJ, Cerami A: Non-enzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J Exp Med 1979, 150:1098-1107.
7. Delgado-Andrade C: Maillard reaction products: some considerations on their health effects. Clin Chem Lab Med 2014, 52:53-60.
8. Gonzalez I, Romero J, Rodriguez BL, Perez-Castro R, Rojas A: The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology 2013, 218:790-797.
9. Kellow NJ, Savige GS: Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review. Eur J Clin Nutr 2013, 67:239-248.
10. Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bugel S, Nielsen J, Skibsted LH, Dragsted LO: Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol 2013, 60:10-37.
11. Tessier FJ: The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris) 2010, 58:214-219.
12. Tessier FJ, Birlouez-Aragon I: Health effects of dietary Maillard reaction products: the results of ICARE and other studies. Amino Acids 2012, 42:1119-1131.
13. Van Nguyen C: Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs. Mol Nutr Food Res 2006, 50:1140-1149.
14. Bastos DHM, Monaro E, Siguemoto E, Sefora M: Maillard reaction products in processed food: pros and cons. In Food Industrial Processes. Edited by Rijeka VB. InTech; 2012:281-300.
15. Arena S, Salzano AM, Renzone G, DAmbrosio C, Scaloni A: Non-enzymatic glycation and glycoxidation protein products in foods and diseases: an interconnected, complex scenario fully open to innovative proteomic studies. Mass Spectrom Rev 2014, 33:49-77.
16. Monnier VM: Intervention against the Maillard reaction in vivo. Arch Biochem Biophys 2003, 419:1-15.
17. Sorci G, Riuzzi F, Giambanco I, Donato R: RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta 2013, 1833:101-109.
18. Kotani K, Caccavello R, Taniguchi N, Gugliucci A: Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in asymptomatic subjects. J Int Med Res 2012, 40:1878-1883.
19. Basta G, Schmidt AM, de Caterina R: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004, 63:582-592.
20. Baumann M: Role of advanced glycation end products in hypertension and cardiovascular risk: human studies. J Am Soc Hypertens 2012, 6:427-435.
21. Yan SF, Ramasamy R, Schmidt AM: Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 2010, 79:1379-1386.
22. Manigrasso MB, Juranek J, Ramasamy R, Schmidt AM: Unlocking the biology of RAGE in diabetic microvascular complications. Trends Endocrinol Metab 2014, 25:15-22.
23. Ibrahim ZA, Armour CL, Phipps S, Sukkar MB: RAGE and TLRs: relatives, friends or neighbours? Mol Immunol 2013, 56:739-744.
24. Uribarri J, Woodruff S, Goodman S, Cai WJ, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H: Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010, 110:911-916.
25. He CJ, Sabol J, Mitsuhashi T, Vlassara H: Dietary glycotoxins - inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes 1999, 48:1308-1315.
26. Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H: Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997, 94:6474-6479.
27. Faist V, Erbersdobler HF: Metabolic transit and in vivo effects of melanoidins and precursor compounds deriving from the Maillard reaction. Ann Nutr Metab 2001, 45:1-12.
28. Forster A, Kuhne Y, Henle T: Studies on absorption and elimination of dietary Maillard reaction products. Maillard React Chem Interface Nutr Aging Dis 2005, 1043:474-481.
29. Vlassara H, Striker GE: Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am 2013, 42:697.
30. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, it-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM: A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 2010, 91:1220-1226.
31. Uribarri J, Cai WJ, Sandu O, Peppa M, Goldberg T, Vlassara H: Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Maillard React Chem Interface Nutr Aging Dis 2005, 1043:461-466.
32. Vlassara H, Uribarri J, Ferrucci L, Cai WJ, Torreggiani M, Post JB, Zheng F, Striker GE: Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol 2009, 29:594-603.
33. Hanssen NMJ, Engelen L, Ferreira I, Scheijen JLJM, Huijberts MS, van Greevenbroek MMJ, van der Kallen CJH, Dekker JM, Nijpels G, Stehouwer CDA, Schalkwijk CG: Plasma levels of advanced glycation endproducts N-is an element of- (carboxymethyl)lysine, N-is an element of- (carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies. J Clin Endocrinol Metab 2013, 98:E1369-E1373.
34. Vlassara H, Uribarri J: Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diabetes Rep 2014:14.
35. van Boekel MAJS: Formation of flavour compounds in the Maillard reaction. Biotechnol Adv 2006, 24:230-233.
36. Yaylayan VA: Classification of the Maillard reaction: a conceptual approach. Trends Food Sci Technol 1997, 8:13-18.
37. Han LP, Li L, Li B, Zhao D, Li YT, Xu ZB, Liu GQ: Review of the characteristics of food-derived and endogenous N-epsiloncarboxymethyllysine. J Food Prot 2013, 76:912-918.